Extracellular Vesicles in Cancer Metabolism: Implications for Cancer Diagnosis and Treatment. (23rd August 2021)

• Record Type: Journal Article
• Authors: Zhang, Qian; Yang, Xiangling; Liu, Huanliang
• Is Part Of: Technology in cancer research & treatment. Volume 20(2021)
• Publication Date: 2021-08-23
• Subjects: exosomes -- metabolic reprogramming -- cancer cells -- glucose -- amino acids -- lipids -- biomarkers; Oncology -- Periodicals; Cancer -- Diagnosis -- Periodicals; Cancer -- Treatment -- Technological innovations -- Periodicals; 616.994
• DOI: 10.1177/15330338211037821
• Languages: English
• ISSNs: 1533-0346

Abstract

Metabolic reprogramming is one of the most common characteristics of cancer cells. The metabolic alterations of glucose, amino acids and lipids can support the aggressive phenotype of cancer cells. Exosomes, a kind of extracellular vesicles, participate in the intercellular communication through transferring bioactive molecules. Increasing evidence has demonstrated that enzymes, metabolites and non-coding RNAs in exosomes are responsible for the metabolic alteration of cancer cells. In this review, we summarize the past and recent findings of exosomes in altering cancer metabolism and elaborate on the role of the specific enzymes, metabolites and non-coding RNAs transferred by exosomes. Moreover, we give evidence of the role of exosomes in cancer diagnosis and treatment. Finally, we discuss the existing problems in the study and application of exosomes in cancer diagnosis and treatment.